HICP - Tea, mate and other plant-derived products for infusion (ND) in Czechia
Czechia: HICP - Tea, mate and other plant-derived products for infusion (ND) was 1.49 in 2026. ▼ Falling
Latest (2026)
1.49
Change on year
down 8.6%
World rank
8th
of 27 countries
All-time high
2.72
in 2000
All-time low
1.49
in 2026
Years of data
27
2000–2026
HICP - Tea, mate and other plant-derived products for infusion (ND) in Czechia, 2000–2026
Source: European Central Bank.
Analysis
The most recent figure for hicp - tea, mate and other plant-derived products for infusion (nd) in Czechia is 1.49, measured in 2026. That is the lowest value across all 27 years on record.
The figure is down 8.6% on the previous year and down 29.7% over ten years.
Over the whole period, hicp - tea, mate and other plant-derived products for infusion (nd) in Czechia peaked at 2.72 in 2000 and was at its lowest, 1.49, in 2026.
Czechia ranks 8th of 27 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 27 years of available data.
HICP - Tea, mate and other plant-derived products for infusion (ND) in Czechia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 2.72 | — |
| 2001 | 2.44 | -10.3% |
| 2002 | 2.26 | -7.4% |
| 2003 | 1.95 | -13.7% |
| 2004 | 1.93 | -1.0% |
| 2005 | 1.98 | +2.6% |
| 2006 | 1.77 | -10.6% |
| 2007 | 1.78 | +0.6% |
| 2008 | 1.83 | +2.8% |
| 2009 | 1.98 | +8.2% |
| 2010 | 2.08 | +5.1% |
| 2011 | 2.02 | -2.9% |
| 2012 | 1.73 | -14.4% |
| 2013 | 1.79 | +3.5% |
| 2014 | 1.9 | +6.1% |
| 2015 | 1.97 | +3.7% |
| 2016 | 2.12 | +7.6% |
| 2017 | 2.12 | +0.0% |
| 2018 | 2.06 | -2.8% |
| 2019 | 2.03 | -1.5% |
| 2020 | 2.02 | -0.5% |
| 2021 | 2.04 | +1.0% |
| 2022 | 2 | -2.0% |
| 2023 | 1.91 | -4.5% |
| 2024 | 1.69 | -11.5% |
| 2025 | 1.63 | -3.6% |
| 2026 | 1.49 | -8.6% |
Czechia compared with similar countries
- Czechia's 1.49 is above the median for Europe & Central Asia, which is 0.92, 1.6× the median. (26 countries reporting)
- Czechia's 1.49 is above the median for high income countries, which is 0.92, 1.6× the median. (27 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.06 | 1.77 | 2.72 | 10 |
| 2010s | 1.98 | 1.73 | 2.12 | 10 |
| 2020s | 1.83 | 1.49 | 2.04 | 7 |
Countries ranked near Czechia
More economy & growth data for Czechia
- Africa's Development Dynamics (AfDD) Table 04 - Annual real GDP 2.31 Percent per annum (2029)
- Africa's Development Dynamics (AfDD) Table 02 - Annual real GDP 2.3 Percent per annum (2029)
- Foreign direct investment, net outflows (BoP, current US$), gaps 8.62 billion BoP, current US$ (2025)
- Foreign direct investment, net outflows (BoP, current US$), per unit 0.022 BoP, current US$ per US$ of GDP (2025)
- Foreign direct investment, net outflows (BoP, current US$), per capita 791.69 BoP, current US$ per person (2025)
- Foreign direct investment, net inflows (BoP, current US$), gaps filled 10.50 billion BoP, current US$ (2025)
- Foreign direct investment, net inflows (BoP, current US$), annual -22.27 % change on previous year (2025)
- Foreign direct investment, net inflows (BoP, current US$), per unit 0.0269 BoP, current US$ per US$ of GDP (2025)
- Foreign direct investment, net inflows (BoP, current US$), per capita 964.82 BoP, current US$ per person (2025)
- Total reserves (includes gold, current US$), annual growth rate 20.54 % change on previous year (2025)
Frequently asked questions
- What is hicp - tea, mate and other plant-derived products for infusion (nd) in Czechia?
- Hicp - tea, mate and other plant-derived products for infusion (nd) in Czechia was 1.49 in 2026, according to European Central Bank.
- What is the highest hicp - tea, mate and other plant-derived products for infusion (nd) recorded in Czechia?
- The highest recorded value was 2.72 in 2000.
- What is the lowest hicp - tea, mate and other plant-derived products for infusion (nd) recorded in Czechia?
- The lowest recorded value was 1.49 in 2026.
- How does Czechia rank for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Czechia ranks 8th out of 27 countries with data for 2026.
- Is hicp - tea, mate and other plant-derived products for infusion (nd) rising or falling in Czechia?
- Over the last ten years it is down 29.7%. The long-run trend across the full record is falling.
- Where does this Czechia data come from?
- The figures come from European Central Bank, published as part of HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 27 observations, free to reuse under ECB Terms and Conditions (attribution required).